Changing priorities in vaccinology: Antibiotic resistance moving to the top

Frontiers in Immunology

Volumn 9, Issue MAY, 2018, Pages

  Tagliabue, Aldo ^a   Rappuoli, Rino ^b  

^a Milan Unit   (Italy)

^b GSK   (Italy)

Author keywords

Antibiotic resistance; Human immunology; Public health; Reverse vaccinology; Vaccination

Indexed keywords

RECOMBINANT DNA; VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBODY RESPONSE; CHEMOTHERAPY; CHRONIC DISEASE; GENE EXPRESSION; GENE REARRANGEMENT; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; LIFE EXPECTANCY; MENINGITIS; NONHUMAN; PASSIVE IMMUNIZATION; REVIEW; VACCINATION; WHOLE GENOME SEQUENCING; WORLD HEALTH ORGANIZATION;

EID: 85047824702     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2018.01068     Document Type: Review

References (47)

1. Microbes maketh man. Economist (2012). Available from: https://www.economist.com/node/21560559 (Accessed: August 18, 2012)
2. Sender R, Fuchs S, Milo R. Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell (2016) 164:337-40. doi:10.1016/j.cell.2016.01.013
3. Rappuoli R. Vaccine science, health, longevity, and wealth. Proc Natl Acad Sci U S A (2014) 111:1282. doi:10.1073/pnas.1413559111
4. Roser M. Child Mortality (2018). Published online at OurWorldInData.org. Retrieved from: https://ourworldindata.org/child-mortality [Online Resource]
5. Tiberio V. Sugli estratti di alcune muffe. Annali di Igiene sperimentale (1895) V:55-67
6. Duchesne E. Contribution à l'étude de la concurrence vitale chez les micro-organismes: antagonisme entre les moisissures et les microbes. Thesis, Alexandre Rey, Lyon, France (1897)
7. Fleming A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. Br J Exp Pathol (1929) 10:226-36
8. Falkow S. Infectious Multiple Drug Resistance. London: Pion Limited (1975). 300 p
9. Li Y, Hill A, Beitelshees M, Shao S, Lovell JF, Davidson BA, et al. Directed vaccination against pneumococcal disease. Proc Natl Acad Sci U S A (2016) 113:6898-903. doi:10.1073/pnas.1603007113
10. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, et al. Global, regional and national causes of child mortality: a systematic approach. Lancet (2010) 375:1969-87. doi:10.1016/S0140-6736(10)60549-1
11. O'Neil J. Tackling drug-resistant infections globally: final report and recommendations. In: Ro A, editor. Resistance (Vol. 1). London, United Kingdom (2016). 84 p
12. Payne DJ, Federici ML, Findlay D, Anderson J, Marks L. Time for a change: addressing R&D and commercialization challenges for antibacterials. Phi Trans R Soc (2015) 370:20140086. doi:10.1098/rstb.2014.0086
13. Mishra RP, Oviedo-Orta E, Prachi P, Rappuoli R, Bagnoli F. Vaccines and antibiotic resistance. Curr Opin Microbiol (2012) 15:596-602. doi:10.1016/j.mib.2012.08.002
14. Kennedy DA, Read AF. Why does drug resistance readily evolve but vaccine resistance does not? Proc Biol Sci (2017) 284:20162562. doi:10.1098/rspb.2016.2562
15. Saul A, Rappuoli R. The Novartis vaccines institute for global health: a new initiative for developing vaccines for neglected diseases in developing countries. J Infect Dev Countries (2009) 2:154-5. doi:10.3855/T2.2.154
16. Rappuoli R, Pizza MG. Vaccines against meningococcus. Vaccine (2009) 27(Suppl 2):B1-126
17. Rappuoli R, Del Giudice G, Nabel GJ, Osterhaus AD, Robinson R, Salisbury D, et al. Rethinking influenza. Science (2009) 326:50. doi:10.1126/science.1179475
18. Black S, Rappuoli R. A crisis of public confidence in vaccines. Sci Transl Med (2010) 2:61mr1. doi:10.1126/scitranslmed.3001738
19. Black S, Pizza M, Nissum M, Rappuoli R. Towards a meningitis-free world. Sci Transl Med (2012) 4:123s5. doi:10.1126/scitranslmed.3003859
20. Black S, Margarit I, Rappuoli R. Preventing newborn infection with maternal immunization. Sci Transl Med (2013) 5:195s11. doi:10.1126/scitranslmed.3005451
21. Black S, De Gregorio E, Rappuoli R. Developing vaccines for an aging population. Sci Transl Med (2015) 7:281s8. doi:10.1126/scitranslmed.aaa0722
22. Barocchi MA, Black S, Rappuoli R. Multicriteria decision analysis and core values for enhancing vaccine-related decision-making. Sci Transl Med (2016) 8:345s14. doi:10.1126/scitranslmed.aaf0756
23. Bloom DE, Black S, Rappuoli R. Emerging infectious diseases: a proactive approach. Proc Natl Acad Sci U S A (2017) 114:4055-9. doi:10.1073/pnas.1701410114
24. Abbott A. Vaccines promoted as key to stamping out drug-resistant microbes. Nature (2017). doi:10.1038/nature.2017.22324
25. The value of vaccines in the avoidance of antimicrobial resistance. Chatham House Meeting. London: Royal Society (2017). p. 29-30
26. Hampton LM, Farley MM, Schaffner W, Thomas A, Reingold A, Harrison LH, et al. Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines. J Infect Dis (2012) 205:401-11. doi:10.1093/infdis/jir755
27. Rappuoli R, Bloom DE, Black S. Deploy vaccines to fight superbugs. Nature (2017) 552:165-7. doi:10.1038/d41586-017-08323-0
28. Rappuoli R. Reverse vaccinology. Curr Opin Microbiol (2000) 3:445-50. doi:10.1016/S1369-5274(00)00119-3
29. Serruto D, Bottomley MJ, Sanjay R, Giuliani MM, Rappuoli R. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigen. Vaccine (2012) 30:B87-97. doi:10.1016/j.vaccine.2012.01.033
30. Rappuoli R, Bottomley MJ, D'Oro U, Finco O, De Gregorio E. Reverse vaccinology 2.0: human immunology instructs vaccine antigen design. J Exp Med (2016) 213:469-81. doi:10.1084/jem.20151960
31. Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR, et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med (2004) 10:871-5. doi:10.1038/nm1080
32. Malito E, CarfiA, Bottomley MJ. Protein crystallography in vaccine research and development. Int J Med Sci (2015) 16:13106-40. doi:10.3390/ijms160613106
33. Liljeroos L, Malito E, Ferlenghi I, Bottomley MJ. Structural and computational biology in the design of immunogenic vaccine antigens. J Immunol Res (2015) 2015:156241. doi:10.1155/2015/156241
34. Macagno A, Bernasconi NL, Vanzetta F, Dander E, Sarasini A, Revello MG, et al. Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL7UL128-131A complex. J Virol (2010) 84:1005-13. doi:10.1128/JVI.01809-09
35. Kabanova A, Perez L, Lilleri D, Marcandalli J, Agatic G, Becattini S, et al. Antibody-driven design of a human cytomegalovirus ghgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies. Proc Natl Acad Sci U S A (2014) 111:17965-70. doi:10.1073/pnas.1415310111
36. McLellan JS, Chen M, Leung S, Graepel KW, Du X, Yang Y, et al. Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralization antibody. Science (2013) 340:1113-7. doi:10.1126/science.1234914
37. Corti D, Bianchi S, Vanzetta F, Minola A, Perez L, Agatic G, et al. Cross-neutralization of four paramyxoviruses by human monoclonal antibody. Nature (2013) 501:439-43. doi:10.1038/nature12442
38. Petousis-Harris H, Paynter J, Morgan J, Saxton P, McArdle B, Goodyear-Smith F, et al. Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study. Lancet (2017) 390:1603-10. doi:10.1016/S0140-6736(17)31449-6
39. Dethlefsen L, Eckburg PB, Bik EM, Relman DA. Assembly of the human intestinal microbiota. Trends Ecol Evol (2006) 21:517-23. doi:10.1016/j.tree.2006.06.013
40. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A (2004) 101:15718-23. doi:10.1073/pnas.0407076101
41. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell (2004) 118:229-41. doi:10.1016/j.cell.2004.07.002
42. Noverr MC, Huffnagle GB. Does the microbiota regulate immune responses outside the gut? Trends Microbiol (2004) 12:562-8. doi:10.1016/j.tim.2004.10.008
43. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A (2011) 108:4680-7. doi:10.1073/pnas.1002611107
44. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A (2005) 102:11070-5. doi:10.1073/pnas.0504978102
45. Neuman MG, Nanau RM. Inflammatory bowel disease: role of diet, microbiota, life style. Transl Res (2012) 160:29-44. doi:10.1016/j.trsl.2011.09.001
46. Simrén M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut (2013) 62:159-76. doi:10.1136/gutjnl-2012-302167
47. Penders J, Thijs C, van den Brandt PA, Kummeling I, Snijders B, Stelma F, et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA birth cohort study. Gut (2007) 56:661-7. doi:10.1136/gut.2006.100164